Takeda Pharmaceutical Co. $TAK Shares Acquired by JPMorgan Chase & Co.

robot
Abstract generation in progress

JPMorgan Chase & Co. increased its stake in Takeda Pharmaceutical by 37.7%, now holding 247,529 shares valued at $3.62 million. Takeda missed its most recent quarterly earnings and revenue estimates, reporting $0.48 EPS against $0.55 expected, and $7.60 billion in revenue versus $7.81 billion expected. The stock currently has a “Hold” consensus rating from analysts, with a market cap of approximately $59.6 billion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin